A patient receives an oral medication that undergoes significant first-pass metabolism. If hepatic enzyme activity is substantially induced, which consequence follows?

💡 Explanation

Increased hepatic enzyme activity enhances first-pass metabolism, breaking down more of the drug before it reaches systemic circulation; because of this, less drug is available. Therefore, bioavailability decreases, rather than increasing plasma concentration or effectiveness. Half-life isn't necessarily prolonged.

• If a person's sebum production decreases substantially while living in a cold, dry climate, which consequence follows regarding skin integrity?
• A patient experiences increasing shortness of breath, normal blood pressure, and pulmonary congestion. What causes this effect when cardiac output falls despite elevated sympathetic activity?
• A food manufacturer uses a novel bitter-masking compound which prevents activation of the TAS2R38 receptor. If a supertaster consumes a product with this compound, which consequence follows?
• Which endocrine imbalance causes ovarian hyperstimulation syndrome (OHSS)?
• Why does progressive presbyopia necessitate increasingly stronger reading glasses as individuals age?
• If a patient's adaptive immune response to a novel viral infection is slow, which consequence involving interferon signaling is most likely?